Eligibility rules have changed

Cascade Regional Blood Services has made some changes to donor eligibility based on new FDA guidance. The FDA revised several policies based on completed studies and epidemiological data.

In summary, the following changes have been implemented:

  • Deferrals for certain HIV risks factors have been reduced from a 12 month deferral to a 3 month deferral
  • Certain malaria risk factors have also been reduced from a 12 month deferral to a 3 month deferral
  • The deferral for donors who have spent time at military bases in Europe due to potential risk of Creutzfeldt-Jakob, or Variant Creutzfeldt-Jakob, has been removed

To read more about the FDA changes, click the link below for the full announcement.

The FDA continues to work on MSM deferral criteria

Cascade Regional Blood Services is committed to maintaining a safe and available blood supply and treating all potential donors with fairness, equality and respect. To that end, we strongly support ongoing research initiatives designed to determine if donor-screening alternatives based on individual behaviors, not based on sexual or gender identity, will provide equivalent or superior transfusion safety. We encourage the Food and Drug Administration (FDA) to continue its examination of deferral criteria for men who have had sex with men (MSM) to ensure the use of rational, science-based deferral periods that are applied fairly and consistently among blood donors.

Read more about the FDA changes